Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

1st Quarter Results

Regulatory Announcement Royal Bank of Canada February 28, 2024 First Quarter 2024 Earnings Release The First Quarter 2024 Earnings Release has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism To view the full document, please paste the following URL into the address bar of your browser. First Quarter 2024 Earnings Release dated February 28, 2024 http://www.rns-pdf.londonstockexchange.com/rns/8401E_1-2024-2-28.pdf A copy of the First Quarter 2024 Earnings Release

1st Quarter Results

Regulatory Announcement Royal Bank of Canada February 28, 2024 First Quarter Results The First Quarter 2024 Report to Shareholders has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism To view the full document, please paste the following URL into the address bar of your browser. First Quarter 2024 Report to Shareholders dated February 28, 2024 http://www.rns-pdf.londonstockexchange.com/rns/8407E_1-2024-2-28.pdf A copy of the First Quarter 2024 Report to

Newsletter focusing on the sales launch of Zeqmelit®

The sales launch of Zeqmelit® is the theme of AcuCort's newsletter #3, which is being published today.The first commercial order of Zeqmelit® is the featured topic of the newsletter. Jonas Jönmark, CEO of AcuCort, discusses how the company is working to support sales efforts and prepare for the launch. The newsletter can be read via the following link: https://mailchi.mp/acucort/acucort-newsletter-february2024 To subscribe, register here: https://www.acucort.se/en/#mailchimp-module

Nordic Mining ASA: Mandatory notification of trade by close associate of primary insider

Exman AS, a closely associated enterprise of Jens Gisle Schnelle, Interim Chief Financial Officer and primary insider in Nordic Mining ASA, has today 28 February 2024 purchased 700,000 shares in Nordic Mining ASA at a price of NOK 0.7176 per share. Following this transaction, Jens Gisle Schnelle and closely related parties hold 700,000 shares in Nordic Mining ASA. For more information see the attached mandatory notification of trade. Oslo, 28 February 2024Nordic Mining ASA This information is subject to disclosure requirements set out in the Market Abuse Regulation EU 596/2014

New top ranking for Karolinska University Hospital in global hospital ranking

Karolinska once again achieves a prominent position in Newsweek magazine's ranking World's Best Hospitals. For the fifth year in a row, the hospital is in the top 10 and ranks seventh in the world.Newsweek's ranking is the only worldwide comparison made. It's based on four data sources: · Recommendations from experts in the health sector, such as doctors and managers. 85,000 experts from around the world were invited, and responses were provided by a large number of them. · Results of patient surveys, for example regarding treatment and information. · Quality outcomes, such as

Best Home Insurance in Ontario 2024: A Comprehensive Guide

[Compare home insurance companies] Home insurance stands as a crucial shield for Ontario homeowners, safeguarding their property and assets against potential losses or disasters. Given the plethora of choices, finding the ideal home insurance policy tailored to your specific requirements can prove challenging. This comprehensive guide will help you understand the various coverage options and factors to consider, as well as provide tips for finding the best home insurance in Ontario. Whether you're a first-time homebuyer or an experienced homeowner, this guide will give you the

Letter from the CEO: CS MEDICA's 2024 Progress Report

CS MEDICA Provides Insights on Continued Growth and Strategic Health.As a follow-up to our Annual Report, we're still navigating through the complexities of our industry as a scale-up MedTech and the challenges that come our way. I want to address some concerns that have been raised regarding CS MEDICA's financial capacity and the impact these factors may have on our growth and overall company health.   Despite the hurdles, our strategic focus and operational adjustments yield tangible results. We are witnessing an uplift in customer acquisition, with registrations and patents increasing

Atria buys two pig farms in Estonia

Atria Estonia invests in local pork production in Estonia and buys two pig farms in Southern Estonia, Veelikse village, Mulgimaa. The consumption of pork in Estonia has been stable, and with the acquisition, Atria aims to ensure the supply of domestic pork in the future as well. − In Estonia, pork self-sufficiency is about 70 percent, and it is very important for us to be able to offer domestic pork to consumers. After this acquisition, Atria owns 6 pig farms in Estonia, with an annual production of about 5 million kilos, says Atria Estonia’s Managing Director Olle Horm. − We are

Grant of warrants and adjustments to terms of existing retention program

MapsPeople A/S I Grant of warrants and adjusted warrants terms Company Announcement No. 2 - 2024 Aalborg, February 28, 2024 Grant of warrants In order to implement a retention and incentive program, the board of directors of MapsPeople today exercised part of its authorization in section 4.16 of MapsPeople’s articles of association to issue a total of 550,000 warrants. The warrants were issued to Christian Læsø and one key employee. The exercise price is fixed at DKK 1.19 per share corresponding to the subscription price at the latest private placement in December 2023 as

Neonode Reports 2023 Financial Results

STOCKHOLM, SWEDEN, February 28, 2024 — Neonode Inc. (NASDAQ: NEON) today reported financial results for the fiscal year ended December 31, 2023.FINANCIAL SUMMARY FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023: · Revenue of $4.4 million, a decrease of 21.5% compared to the prior year. · Operating expenses of $10.7 million, an increase of 4.9% compared to the prior year. · Net loss of $10.1 million, or $0.66 per share, compared to $4.9 million, or $0.36 per share, for the prior year. · Cash used by operations of $6.3 million, compared to $6.8 million for the prior year. · Cash

Aptahem’s scientific manuscript now published in the journal Cells

Aptahem announced on the 27 February 2024 that the company’s scientific manuscript had been accepted for publication in the journal Cells. Today, the 28 February 2024, the paper has been published.The title of the manuscript is ”Therapeutic effects of a novel aptamer on coronaviral infection induced lung injury and systemic inflammatory responses” and can be accessed via this link . The manuscript describes the results of the preclinical studies performed in SARS Corona virus models in collaboration with the research group in Toronto, which indicate

Holding(s) in Company

TR-1: Standard form for notification of major holdings [][][][][][][]NOTIFICATION OFMAJOR HOLDINGS(tobe sent to therelevant issuerandto the FCA inMicrosoft Wordformatif possible) [i] 1a. Identity of Oscillate Plcthe issuer or theunderlying issuerof existingsharesto which votingrights areattached[ii]:1b. Pleaseindicate if theissuer isa non-UK issuer (please markwithan “X” ifappropriate)Non-UK issuer2. Reason for thenotification(please mark theappropriate boxorboxes with an“X”)An

AcuCort presents at three events for investors

AcuCort will participate in three investor presentations during March. CEO Jonas Jönmark will summarize the latest news and discuss the launch of the oral film Zeqmelit®.What does the process look like regarding the launch of the oral film Zeqmelit® and how will the company evolve with the transition from a research company to a pharmaceutical company? These are the key areas that will be addressed when AcuCort's CEO Jonas Jönmark participates in Stora Aktiedagen, Invest Live, and Stockholm Corporate Finance Capital Markets Days Life Science in the near future. Information about the

Techstep signs strategic partnership agreement with devicenow for Lifecycle Portal

Techstep has entered into a strategic partnership agreement with devicenow, a global provider of subscription-based IT devices, to introduce Lifecycle Portal to a wider customer base worldwide. Lifecycle Portal is Techstep’s proprietary software for automated device lifecycle management. It enables customers to control every lifecycle event of their device estate from purchase and onboarding to offboarding and recycling. Lifecycle Portal allows customers to free up time, reduce cost, and adopt more sustainable practices in device handling. Devicenow, a German-based company and part of

Hufvudstaden’s Annual and Sustainability Report 2023

Hufvudstaden’s Annual and Sustainability Report for 2023 is now available on our website hufvudstaden.se . A printed version will be distributed to shareholders and other stakeholders upon request. The report can also be ordered on the website hufvudstaden.se/en/investor-relations/reports-and-presentations . Stockholm February 28, 2024HUFVUDSTADEN AB (publ)  Questions can be answered by Åsa Roslund, Vice President and CFO,telephone +46 8 762 90 00.

Rottneros’ Annual Report 2023 published

The Swedish version of Rottneros’ Annual Report for 2023, which also includes a sustainability report, is now available on the company's webpage, rottneros.se.The English version is expected to be published during week 13 2024. Shareholders and other interested parties who wish to have printed copies of the Annual Report may order it by email info@rottneros.com. Distribution of the printed annual report in Swedish is expected to take place in week 12 2024, and in English in week 16 2024. For more information please contact:Monica Pasanen, CFO, Rottneros AB, +46 (0)270 622 70, monica.

E-commerce peer community Digital Commerce Finland launches annual summit and award gala

Digital Commerce Finland’s goal is to build the world’s most competitive digital commerce community in Finland and increase the attractiveness of the industry. With the eCom Summit & Awards event, the largest of its kind in Finland, the community highlights people and companies engaged in successful e-commerce.HELSINKI, Finland (February 28th, 2024) The eCom Summit & Awards event, to be held in Helsinki in May, will be the biggest annual e-commerce event in Finland. The event will begin with a seminar, with prominent speakers such as Anna Carolina Wiklund, Capability Manager from Inter Ikea;

Observe Medical – First order to Germany

Oslo, February 28, 2024 - Observe Medical ("the Company" or "Observe Medical") has received the first order for its UnoMeter products from Siramo GmbH, following the strategic Letter of Intent (LOI) announced in December 2023. This order marks the expansion into the German market, a key territory for the distribution of the UnoMeter product range. The founders of Siramo GmbH are industry experts with a rich background from the former largest Convatec distributor in Germany for UnoMeter. Therefore, this initial order and our formalized agreement represents a significant step towards

Operations of Metsä Group’s Merikarvia sawmill to close down

The change negotiations concerning the Merikarvia sawmill of Metsä Fibre, part of Metsä Group, which began in January, have ended. After the change negotiations, the company decided to close down the operations of the Merikarvia sawmill by the end of June 2024.The negotiations concerned all 79 employees of the sawmill. The negotiations covered the reasons for the closure of the sawmill, the possible substantial and permanent reduction in work resulting from the planned closure and the necessary personnel arrangements. Efforts will be made to offer the permanent personnel of the Merikarvia

Smoltek has been granted three new patents – all in the field of reducing contact resistance in electrolyzer and fuel cells

This press release is an English version of the previously published Swedish version, which has interpretive precedence. Smoltek Nanotech Holding AB (“Smoltek”) announces that the company has been awarded three new patents. The patents are divided into three new and separate patent families, all related to how Smoltek’s technology can reduce contact resistance between different layers in electrochemical cells, mainly for use in electrolyzers and fuel cells. These new patents also bring the IP portfolio to comprise 87 granted patents.Smoltek has been awarded three new patents. Each one of

Nightingale Health to publish half-year report for July – December 2023 on 7 March 2024

Press release, 28 February 2024 at 2:15 p.m. (EET)   Nightingale Health Plc will publish its half-year report for July – December 2023 on Thursday 7 March 2024 at around 9 a.m. EET. The materials will be made available soon after publication at nightingalehealth.com/investors.   Nightingale Health will arrange a live webcast for investors and media in English on 7 March 2024 at 2 p.m. EET. You can watch the webcast online at https://nightingalehealth.videosync.fi/2023-2024-h1-results.   A presentation will be held by CEO Teemu Suna and CFO Tuukka Paavola. A recording of

Capsol Technologies ASA: New share capital registered

Oslo, Norway - 18 February 2024Reference is made to the stock exchange announcement published by CapsolTechnologies ASA (the "Company") on 16 February 2024 regarding a successfulcompletion of a private placement in the Company (the "Private Placement").The share capital increase pertaining to the issuance of 7,005,274 new shares inthe Company has today been registered with the Norwegian Register of BusinessEnterprises (Nw. Foretaksregisteret).The Company’s new share capital is NOK 30,269,334.50 divided into 60,538,669shares, each with a nominal value of NOK 0.5.For further

Director/PDMR Shareholding

Fidelity Special Values PLC Director Shareholding The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation 1 Details of the person discharging managerial  responsibilities / person closely associated  a) Name Mr Ominder Dhillon     2 Reason for the notification    a) Position/status Non-executive director (PDMR)     b) Initial notification Initial notification /Amendment    3 Details of the issuer, emission

There are no items matching the current filter
There are no more items matching the current filter
Back to top